Oliver Koch

Edinburgh, SCT, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Complementing the case for standardized travel health competencies: a UK perspective.

Complementing the case for standardized travel health competencies: a UK perspective.

Journal: Journal of travel medicine

Published: July 21, 2025

Yellow fever in South America - A plea for action and call for prevention also in travelers from SLAMVI, ESGITM, EVASG, ALEIMC, GEPI-SEIMC, SEMEVI, and CMTZMV-ACIN.

Yellow fever in South America - A plea for action and call for prevention also in travelers from SLAMVI, ESGITM, EVASG, ALEIMC, GEPI-SEIMC, SEMEVI, and CMTZMV-ACIN.

Journal: Travel medicine and infectious disease

Published: June 29, 2025

Human granulocytic anaplasmosis in a Scottish traveller returning from Canada.

Human granulocytic anaplasmosis in a Scottish traveller returning from Canada.

Journal: Travel medicine and infectious disease

Published: November 23, 2023

The PATH to PPE Mastery - Programme for Assessment and Training in HCID (High Consequence Infectious Diseases) PPE (Personal Protective Equipment), Mastery.

The PATH to PPE Mastery - Programme for Assessment and Training in HCID (High Consequence Infectious Diseases) PPE (Personal Protective Equipment), Mastery.

Journal: Infection prevention in practice

Published: January 09, 2023

Performance status: A key factor in predicting mortality in the first wave of COVID-19 in South-East Scotland.

Performance status: A key factor in predicting mortality in the first wave of COVID-19 in South-East Scotland.

Journal: The journal of the Royal College of Physicians of Edinburgh

Published: November 12, 2022

An Inhaled Galectin-3 Inhibitor in COVID-19 Pneumonitis: A Phase Ib/IIa Randomized Controlled Clinical Trial (DEFINE).

An Inhaled Galectin-3 Inhibitor in COVID-19 Pneumonitis: A Phase Ib/IIa Randomized Controlled Clinical Trial (DEFINE).

Journal: American journal of respiratory and critical care medicine

Published: August 16, 2022

Evaluation of new or repurposed treatments for COVID-19: protocol for the phase Ib/IIa DEFINE trial platform.

Evaluation of new or repurposed treatments for COVID-19: protocol for the phase Ib/IIa DEFINE trial platform.

Journal: BMJ open

Published: December 16, 2021

Scottish Index of Multiple Deprivation (SIMD) indicators as predictors of mortality among patients hospitalised with COVID-19 disease in the Lothian Region, Scotland during the first wave: a cohort study.

Scottish Index of Multiple Deprivation (SIMD) indicators as predictors of mortality among patients hospitalised with COVID-19 disease in the Lothian Region, Scotland during the first wave: a cohort study.

Journal: International journal for equity in health

Published: November 22, 2021

Randomised controlled trial of intravenous nafamostat mesylate in COVID pneumonitis: Phase 1b/2a experimental study to investigate safety, Pharmacokinetics and Pharmacodynamics.

Randomised controlled trial of intravenous nafamostat mesylate in COVID pneumonitis: Phase 1b/2a experimental study to investigate safety, Pharmacokinetics and Pharmacodynamics.

Journal: EBioMedicine

Published: November 05, 2021

Diagnostic performance of the combined nasal and throat swab in patients admitted to hospital with suspected COVID-19.

Diagnostic performance of the combined nasal and throat swab in patients admitted to hospital with suspected COVID-19.

Journal: BMC infectious diseases

Published: October 29, 2020

Interferon-gamma polymorphisms and risk of iron deficiency and anaemia in Gambian children.

Interferon-gamma polymorphisms and risk of iron deficiency and anaemia in Gambian children.

Journal: Wellcome open research

Published: May 28, 2020

Drive-through testing in COVID-19: experience from NHS Lothian.

Drive-through testing in COVID-19: experience from NHS Lothian.

Journal: Clinical medicine (London, England)

Published: May 17, 2020

Showing 1-12 of 20

Last Updated: 09/26/2026